Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AB, Abraxane, Acceleron, accuracy, acid, acknowledged, ACS, adalimumab, Adam, adjudication, advisory, Aetna, AHR, alan, albumin, alive, alter, Alvogen, Alzheimer, AMPLE, Anagni, analog, anemia, Annex, answer, anticancer, anticompetitive, antigen, antiplatelet, appointed, apremilast, arduini, aspirin, asterisk, Aurobindo, Aurolife, automatic, avoidance, azacitidine, Azar, backup, Baran, BCMA, behavior, bempegaldesleukin, bio, blend, blinded, bluebird, BNP, bonney, Bothell, Breakthrough, Breckenridge, broadly, Brook, built, Canadian, capped, CAR, Cardiology, Catalent, cellular, CELMoD, CEO, cereblon, characterized, Chase, chimeric, chose, Cipla, Citibank, cliff, collar, Columbia, column, comment, Commonwealth, compensatory, complication, concomitantly, conference, congressional, converted, Convertible, converting, County, coupled, coupling, CRNM, custody, cutoff, CVR, daily, Dana, david, deal, Debenture, declaratory, Deferral, deoxyribonucleic, departure, detract, Deutsche, diffuse, diligent, dinesh, display, DLBC, DLBCL, Dohme, doublet, Dr, DRL, DTC, DubowSenior, duly, easement, Eid, Eleventh, embed, encumbrance, engineering, enriched, enrichment, EPd, Equiniti, erythroid, ESCC, escrow, esophageal, Eugia, Evercore, exhausted, Farber, featured, fedratinib, fifty, FL, follicular, forfeiture, forma, formatted, Francisco, FTC, FZE, gave, gemoab, gerald, Gerold, GmbH, GvHD, haller, hampered, Hawaii, HBT, hematologic, hematological, hematology, hematopoietic, heparin, herewith, Hetero, Hirawat, holder, House, HRSA, hypermethylation, identification, IDHIFA, Ikena, immunomodulatory, Imnovid, Importantly, indenture, indirect, indolent, inherited, Inline, Inrebic, insignificant, Inspector, intentionally, interfere, interval, italicized, JNDA, JPMorgan, Jr, julia, Juno, karen, Kettering, Kingdom, Kite, knowingly, Labour, lacy, Language, leasehold, legacy, lengthen, lisocabtagene, LMWH, Logistical, longest, Luxembourg, lymphocytic, lymphoma, maker, Manhattan, maraleucel, mathematical, matthew, MDS, mechanistic, Medarex, mediastinal, Mellon, men, michael, Minister, Ministry, misrepresentation, morale, Mutant, mutationally, myelodysplastic, nab, Natco, nationwide, negligent, neutropenia, noncash, nonperformance, nonvalvular, Notably, notification, Notwithstanding, novo, nucleoside, numerically, OAC, ODAC, OfficerMember, omitted, opportunity, opposed, optimistic, Orlando, OS, Otezla, overarching, overcharged, overcome, ozanimod, paclitaxel, page, paliwal, PBM, PCI, pd, penalty, perception, peter, Pike, Pine, placement, plaintiff, plc, polymorphic, Pomalyst, poster, presence, pro, proceed, proportion, punitive, purified, purport, pyrimidine, QoL, Racketeer, radiation, RBC, Rebloyzl, reblozyl, red, Reddy, reengineer, reengineered, referenced, refile, refused, refusing, Regenerative, rejected, relationship, repeal, resale, Rheumatology, ring, ringed, rituximab, Royal, RRMM, RSU, running, Rupert, salesforce, Sam, Samit, Saratoga, sato, scheme, science, Scotland, sector, seropositive, Sharp, shorten, shown, situation, sJNDA, SKI, slight, Sloan, solution, space, SPARC, SPC, Specimen, storch, strike, subordinated, Suisse, Summit, Sun, symptom, syndrome, syringe, tailored, Taisho, Team, temozolomide, Teva, TGA, thalassemia, thalidomide, Thalomid, theodore, thereto, thereunto, thirteen, threatened, thrombocythemia, thrombocytopenia, treble, trend, trustee, unanticipated, unclear, unconstitutional, undersigned, undeveloped, undiagnosed, unenforceable, unexercised, unfair, unjust, unjustified, unjustly, unknown, unlawful, unrelated, unvested, unwind, unwinding, upper, USA, Vehicle, vera, Vessey, vicki, Vidaza, vivo, VKA, voucher, vousden, Washington, wholly, wild, willfully, window, women, XBRL, xi, yale, Yescarta, Zofingen
Removed:
agile, annualized, antiretroviral, approximated, asunaprevir, atazanavir, autoimmune, beclabuvir, Brazil, breadth, Chinese, cobicistat, cold, Commentary, complementary, concentrated, consultation, creating, daclatasvir, Dafalgan, Daklinza, decompensated, dedicated, deduction, defend, depth, destructive, disgorgement, diversified, duty, efavirenz, Efferalgan, ehf, essential, exclusively, exercising, FCPA, Fervex, flu, generating, hearing, hold, immunoscience, Indiana, infringe, IRS, liquidation, locally, markup, MF, motor, Mount, mUC, multiplied, mutation, nitroxyl, Ohio, organ, organized, PAD, Padlock, predetermined, prepaid, prodrug, Promedior, promised, protease, PTC, ratio, Reckitt, recognizing, rental, replication, retrospectively, SCLC, screen, selective, sensitive, simplified, siRNA, Sublease, substantive, Sunvepra, syndicate, transcriptase, Truvada, turnover, Tybost, typical, unnamed, utility, validated, variation, Vernon, warrant, West
Filing tables
Filing exhibits
- 10-K Annual report
- 4 Contingent Value Rights Agreement Dated November 20, 2019
- 4 Description of Bristol-myers Squibb Companys Securities
- 10 Psu Award Agreement Under the 2012 Stock Award and Incentive Plan
- 10 Psu Award Agreement Under the 2014 Equity Incentive Plan
- 10 Psu Award Agreement Under the 2017 Stock Incentive Plan
- 10 Rsu Agreement with 5-YEAR Vesting Under the 2012 Stock Award and Incentive Plan
- 10 Rsu Agreement with 4-YEAR Vesting Under the 2012 Stock Award and Incentive Plan
- 10 Rsu Agreement with 1-YEAR Cliff Vesting Under the 2012 Stock Award and Incentive
- 10 Rsu Agreement with 2-YEAR Cliff Vesting Under the 2012 Stock Award and Incentive
- 10 Rsu Agreement with 5-YEAR Vesting Under the 2014 Equity Incentive Plan
- 10 Rsu Agreement with 4-YEAR Vesting Under the 2014 Equity Incentive Plan
- 10 Rsu Agreement with 1-YEAR Cliff Vesting Under the 2014 Equity Incentive Plan
- 10 Rsu Agreement with 2-YEAR Cliff Vesting Under the 2014 Equity Incentive Plan
- 10 Rsu Agreement with 5-YEAR Vesting Under the 2017 Stock Incentive Plan
- 10 Rsu Agreement with 4-YEAR Vesting Under the 2017 Stock Incentive Plan
- 10 Rsu Agreement with 1-YEAR Cliff Vesting Under the 2017 Stock Incentive Plan
- 10 Rsu Agreement with 2-YEAR Cliff Vesting Under the 2017 Stock Incentive Plan
- 10 Msu Agreement Under the 2012 Stock Award and Incentive Plan
- 10 Msu Agreement Under the 2014 Equity Incentive Plan
- 10 Msu Agreement Under the 2017 Stock Incentive Plan
- 10 Letter Agreement Between BMS and MR. David Elkins Dated May 30, 2019
- 21 Exhibit 21
- 23 Exhibit 23
- 31 Exhibit 31.A
- 31 Exhibit 31.B
- 32 Exhibit 32.A
- 32 Exhibit 32.B
- Download Excel data file
- View Excel data file
Related press release
Associated BMY transcripts
BMY similar filings
Filing view
External links